The client develops AI-based healthcare applications utilizing genomic data, which require precise DNA sequencing, compliance with strict privacy standards, and robust handling of complex business rules. Manual testing processes are time-consuming and inadequate to cover the expanding suite of applications, leading to increased QA cycle times and potential quality risks. Lack of specialized automation frameworks tailored for genomic and AI model testing hampers efficient release cycles.
A mid-to-large scale healthcare technology company specializing in AI-driven genomic analysis and personalized medicine solutions, with a focus on accelerating drug development and disease diagnosis.
The implementation of a comprehensive, automated testing framework is anticipated to reduce manual testing efforts by over 90 hours per cycle, achieve up to 80% automation coverage of critical applications, and decrease QA cycle times by approximately 95%. This will enable faster development and deployment of AI-powered genomic applications, improve test reliability, and facilitate continuous integration, ultimately supporting the client’s mission to advance precision medicine efficiently and reliably.